These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 29085751)

  • 1. Statins: antimicrobial resistance breakers or makers?
    Ko HHT; Lareu RR; Dix BR; Hughes JD
    PeerJ; 2017; 5():e3952. PubMed ID: 29085751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibacterial effects of statins against bacterial pathogens causing skin infections.
    Ko HHT; Lareu RR; Dix BR; Hughes JD
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1125-1135. PubMed ID: 29569046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins, allies against antibiotic resistance?
    Abavisani M; Hoseinzadeh M; Khayami R; Kodori M; Soleimanpour S; Sahebkar A
    Curr Med Chem; 2023 Aug; ():. PubMed ID: 37644745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An In Vitro Study on the Antibacterial Activity of Statins Against the Most Common Bacterial Pathogens Causing Respiratory Tract Infections in a Tertiary Care Hospital.
    Selva P; Durairajan S
    Cureus; 2024 Apr; 16(4):e58108. PubMed ID: 38741867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are the Statins promising antifungal agents against invasive candidiasis?
    Lima WG; Alves-Nascimento LA; Andrade JT; Vieira L; de Azambuja Ribeiro RIM; Thomé RG; Dos Santos HB; Ferreira JMS; Soares AC
    Biomed Pharmacother; 2019 Mar; 111():270-281. PubMed ID: 30590315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling the Antibacterial Properties of Statins: An
    Ebrahimzadeh M; Asgharpour F; Shokri Shirvani J; Kazemi S; Moghadamnia AA
    Adv Pharmacol Pharm Sci; 2024; 2024():6380155. PubMed ID: 39161645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating the antibacterial effect of the existing antibiotics along with repurposing drug metformin.
    Hossain S; Rafi RH; Ripa FA; Khan MRI; Hosen ME; Molla MKI; Faruqe MO; Al-Bari MAA; Das S
    Arch Microbiol; 2024 Mar; 206(4):190. PubMed ID: 38519821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations.
    Nyilasi I; Kocsubé S; Krizsán K; Galgóczy L; Papp T; Pesti M; Nagy K; Vágvölgyi C
    Med Mycol; 2014 Feb; 52(2):140-8. PubMed ID: 24004389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series.
    Cham S; Koslik HJ; Golomb BA
    Drug Saf Case Rep; 2016 Dec; 3(1):1. PubMed ID: 27747681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma.
    Zhou YY; Zhu GQ; Wang Y; Zheng JN; Ruan LY; Cheng Z; Hu B; Fu SW; Zheng MH
    Oncotarget; 2016 Apr; 7(16):21753-62. PubMed ID: 26943041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro evaluation of the effects of different statins on the structure and function of human gut bacterial community.
    Zhao C; Hu Y; Chen H; Li B; Cao L; Xia J; Yin Y
    PLoS One; 2020; 15(3):e0230200. PubMed ID: 32214324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
    Schachter M
    Fundam Clin Pharmacol; 2005 Feb; 19(1):117-25. PubMed ID: 15660968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
    Brown D
    Nat Rev Drug Discov; 2015 Dec; 14(12):821-32. PubMed ID: 26493767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent.
    Thangamani S; Mohammad H; Abushahba MF; Hamed MI; Sobreira TJ; Hedrick VE; Paul LN; Seleem MN
    Sci Rep; 2015 Nov; 5():16407. PubMed ID: 26553420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIC distribution analysis identifies differences in AMR between population sub-groups.
    Wildfire J; Waterlow NR; Clements A; Fuller NM; Knight GM
    Wellcome Open Res; 2024; 9():244. PubMed ID: 39119595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin: new preparation. Opt for statins with evidence of efficacy on clinical outcome.
    Prescrire Int; 2004 Aug; 13(72):132-4. PubMed ID: 15532136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the pharmacodynamic and pharmacokinetic properties of statins.
    Corsini A; Bellosta S; Baetta R; Fumagalli R; Paoletti R; Bernini F
    Pharmacol Ther; 1999 Dec; 84(3):413-28. PubMed ID: 10665838
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.